Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The tyrosine phosphatases LAR and PTPRδ act as receptors of the nidogen-tetanus toxin complex.

Autor: Surana S; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK. s.surana@ucl.ac.uk.; UCL Queen Square Motor Neuron Disease Centre, University College London, London, WC1N 3BG, UK. s.surana@ucl.ac.uk.; UK Dementia Research Institute, University College London, London, WC1E 6BT, UK. s.surana@ucl.ac.uk., Villarroel-Campos D; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.; UCL Queen Square Motor Neuron Disease Centre, University College London, London, WC1N 3BG, UK.; UK Dementia Research Institute, University College London, London, WC1E 6BT, UK., Rhymes ER; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.; UCL Queen Square Motor Neuron Disease Centre, University College London, London, WC1N 3BG, UK., Kalyukina M; Department of Clinical and Experimental Epilepsy, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK., Panzi C; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.; UCL Queen Square Motor Neuron Disease Centre, University College London, London, WC1N 3BG, UK.; UK Dementia Research Institute, University College London, London, WC1E 6BT, UK., Novoselov SS; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.; UCL Queen Square Motor Neuron Disease Centre, University College London, London, WC1N 3BG, UK., Fabris F; Department of Biomedical Sciences, University of Padova, Padova, 35131, Italy., Richter S; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.; Department of Biomedical Sciences, University of Padova, Padova, 35131, Italy., Pirazzini M; Department of Biomedical Sciences, University of Padova, Padova, 35131, Italy., Zanotti G; Department of Biomedical Sciences, University of Padova, Padova, 35131, Italy., Sleigh JN; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.; UCL Queen Square Motor Neuron Disease Centre, University College London, London, WC1N 3BG, UK.; UK Dementia Research Institute, University College London, London, WC1E 6BT, UK., Schiavo G; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK. giampietro.schiavo@ucl.ac.uk.; UCL Queen Square Motor Neuron Disease Centre, University College London, London, WC1N 3BG, UK. giampietro.schiavo@ucl.ac.uk.; UK Dementia Research Institute, University College London, London, WC1E 6BT, UK. giampietro.schiavo@ucl.ac.uk.

Publikováno v: The EMBO journal [EMBO J] 2024 Aug; Vol. 43 (16), pp. 3358-3387. Date of Electronic Publication: 2024 Jul 08.

The heat-shock response co-inducer arimoclomol protects against retinal degeneration in rhodopsin retinitis pigmentosa.

Autor: Parfitt DA; Ocular Biology and Therapeutics, UCL Institute of Ophthalmology, London, UK., Aguila M; Ocular Biology and Therapeutics, UCL Institute of Ophthalmology, London, UK., McCulley CH; Ocular Biology and Therapeutics, UCL Institute of Ophthalmology, London, UK., Bevilacqua D; Ocular Biology and Therapeutics, UCL Institute of Ophthalmology, London, UK., Mendes HF; Ocular Biology and Therapeutics, UCL Institute of Ophthalmology, London, UK., Athanasiou D; Ocular Biology and Therapeutics, UCL Institute of Ophthalmology, London, UK., Novoselov SS; Ocular Biology and Therapeutics, UCL Institute of Ophthalmology, London, UK., Kanuga N; Ocular Biology and Therapeutics, UCL Institute of Ophthalmology, London, UK., Munro PM; Ocular Biology and Therapeutics, UCL Institute of Ophthalmology, London, UK., Coffey PJ; Ocular Biology and Therapeutics, UCL Institute of Ophthalmology, London, UK., Kalmar B; Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, London, UK., Greensmith L; 1] Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, London, UK [2] MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology, Queen Square, London, UK., Cheetham ME; Ocular Biology and Therapeutics, UCL Institute of Ophthalmology, London, UK.

Publikováno v: Cell death & disease [Cell Death Dis] 2014 May 22; Vol. 5, pp. e1236. Date of Electronic Publication: 2014 May 22.

Molecular chaperone mediated late-stage neuroprotection in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.

Autor: Novoselov SS; UCL Institute of Ophthalmology, London, United Kingdom., Mustill WJ, Gray AL, Dick JR, Kanuga N, Kalmar B, Greensmith L, Cheetham ME

Publikováno v: PloS one [PLoS One] 2013 Aug 30; Vol. 8 (8), pp. e73944. Date of Electronic Publication: 2013 Aug 30 (Print Publication: 2013).

NUB1 modulation of GSK3β reduces tau aggregation.

Autor: Richet E; UCL Institute of Ophthalmology, London, UK., Pooler AM, Rodriguez T, Novoselov SS, Schmidtke G, Groettrup M, Hanger DP, Cheetham ME, van der Spuy J

Publikováno v: Human molecular genetics [Hum Mol Genet] 2012 Dec 15; Vol. 21 (24), pp. 5254-67. Date of Electronic Publication: 2012 Sep 10.